Parenteral lipid nutrition in congenital gastrointestinal malformation operated cases

Timea Brandibur, Aniko Maria Maria, Marioara Boia, Daniel-Dumitru Nisulescu, Alexandru Blidisel, Nilima Rajpal Kundnani, Marius Calin Popoiu

Abstract


Background: Congenital gastrointestinal malformation (CGIM) cases require immediate surgical correction after birth and proper nutrition to meet energy demands. Among the macronutrients, lipids are considered the major energy source, playing a vital role in parenteral nutrition. However, the time of their initiation remains unclear. We compared the data of CGIM cases where lipids were given from the first post-surgical day to those where parenteral lipids were initiated on the second or third day of surgery and then reevaluated them on the seventh day of parenteral nutrition.

Methods: We collected the data of patients who had undergone surgical correction for CGIM and were kept on parenteral nutrition including lipids from day 1 of surgery labeling them as group 1. Group 2 comprised of neonates having lipid parenteral nutrition started from day 2 or 3 of surgery. Both groups were reevaluated on the 7th day of parenteral nutrition. Statistical analysis was performed.

Results: Group 1 had higher total bilirubin (TB) statistically significant (p-value=0.0299), as well as lower lipase (p-value=0.0286), and lower total lipids (p-value=0.0365). The values were lower  of triglycerides (p-value=0.0365), and total lipids (p-value=0.0365), on day 1. Comparing both groups, all biochemical parameters were found to be statistically significant.

Conclusion: Lipid deficiency and overload should be carefully evaluated, especially in neonates having undergone recent surgical interventions, which increase their nutritional demands. No adverse effects were seen in our study related to parenteral lipid emulsion administration in post-surgical congenital gastrointestinal malformation cases. Early initiation of parenteral lipid regimens can provide better outcomes.

Keywords: Congenital gastrointestinal malformations; Intravenous lipid emulsions; Parenteral nutrition; Gestational age; Milk formula 


Full Text:

PDF

References


Corsello G, Giuffrè M. Congenital malformations. Journal of Maternal-Fetal and Neonatal Medicine, (2012); 25(1):125-29.

Congenital disorders. World Health Organization. (date accessed on 23.02.2023)

Brandibur TE, Kundnani NR, Boia M, Nistor D, Velimirovici DM, et al. Does COVID-19 Infection during Pregnancy Increase the Appearance of Congenital Gastrointestinal Malformations in Neonates? Biomedicines, (2023); 1(12): 31205.

Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, et al. National population-based estimates for major birth defects, 2010-2014. Birth Defects Research, (2019); 111(18): 1420-1435.

Chin AM, Hill DR, Aurora M, Spence JR. Morphogenesis and maturation of the embryonic and postnatal intestine. Seminars in Cell & Developmental Biology, (2017); 66: 6681-6693.

Haeusler MC, Berghold A, Stoll C, Barisic I, Clementi M. Prenatal ultrasonographic detection of gastrointestinal obstruction: results from 18 European congenital anomaly registries. Prenatal Diagnosis, (2002); 22(7): 616-623.

Brandibur TE, Manea AM, Sharma A, Kundnani NR, Popoiu MC, et al. Macronutrients Management for Growth in Neonates with Congenital Gastrointestinal Malformation. Medical Science Monitor, (2022); 28e938106.

Hunt RW, Perkins EJ, King S. Peri-operative management of neonates with oesophageal atresia and tracheo-oesophageal fistula. Paediatric Respiratory Reviews, (2016); 19: 3-9.

Gottrand M, Michaud L, Sfeir R, Gottrand F. Motility, digestive and nutritional problems in Esophageal Atresia. Paediatric Respiratory Reviews, (2016); 1928-1933.

World Health Organization: Energy requirements of infants from birth to 12 months. Rome -O, 2001: 11-19; In Human energy requirements. Report of a joint FAO/WHO/UNU expert consultation. (date accessed on 23.02.2023)

Moltu SJ, Bronsky J, Embleton N, Gerasimidis K, Indrio F, et al. Nutritional Management of the Critically Ill Neonate: A Position Paper of the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition, (2021); 73(2): 274-289.

Ludwig K, De Bartolo D, Salerno A, Ingravallo G, Cazzato G, et al. Congenital anomalies of the tubular gastrointestinal tract. Pathologica, (2022); 114(1): 40-54.

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study. Lancet, (2021); 398(10297): 325-339.

Noel P, Emmanuel M. Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions). Best Practice & Research Clinical Gastroenterology, (2022); 56-57:101785.

Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. Journal of Pediatric Gastroenterology and Nutrition, (2005); 41(5): 584-599.

Cai W, Yu L, Lu C, Tang Q, Wan Y, et al. Normal value of resting energy expenditure in healthy neonates. Nutrition, (2003); 19(2): 133-136.

Vanek VW, Allen P, Harvey Banchik LP, Bistrian B, Collier S, et al. Parenteral nutrition intravenous fat emulsions product shortage considerations. Nutrition in Clinical Practice, (2013); 28(4): 528-529.

Uauy R, Koletzko B. Defining the nutritional needs of preterm infants. World Review of Nutrition and Dietetics, (2014); 110: 4-10.

National Guideline A (2020) NICE Evidence Reviews Collection. Lipid emulsions: Neonatal parenteral nutrition: Evidence review D4. London: National Institute for Health and Care Excellence (NICE). (date accessed on 26.02.2023)

Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterally fed term and late preterm infants. Cochrane Database of Systematic Reviews, (2019); 6(6): Cd013171.

Pyles LA NWDolmatINToPseKR, Stanton B, St. Geme, Schor NF, Behrman RE, editor. Philadelphia, United States: Elsevier – Health Sciences Division; 2016:751-764. Chapter: Book Name. of publication; (date accessed on 21.02.2023)

Chandar V, Gidvani CH, Gupta AK, Wilson CG, Sharma YV. LIPID PROFILE IN NORMAL HEALTHY CHILDREN. Medical Journal Armed Forces India, (1994); 50(2): 101-104.

Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, (2017); 38(32): 2459-2472.

Sandström K, Nilsson K, Andréasson S, Olegård R, Larsson LE. Early postoperative lipid administration after neonatal surgery. Acta Paediatrica, (1994); 83(3): 249-254.

Allen SJ. Fluid therapy and outcome: balance is best. The Journal of Extra Corporeal Technology, (2014); 46(1): 28-32.

Guiducci S, Duci M, Moschino L, Meneghelli M, Fascetti Leon F, et al. Providing the Best Parenteral Nutrition before and after Surgery for NEC: Macro and Micronutrients Intakes. Nutrients, (2022); 14(5): 919.

Jochum F, Moltu SJ, Senterre T, Nomayo A, Goulet O, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes. Clinical Nutrition, (2018); 37(6 Pt B): 2344-2353.

Boden G. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sciences, (2003); 72(9): 977-988.

Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics, (2006); 118(5): 1811-1818.

Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. The Journal of Pediatrics, (1999); 134(4): 492-498.

Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). Journal of Pediatric Gastroenterology Nutrition, (2005); 41 Suppl 2S1-87.

Sinclair R, Schindler T, Lui K, Bolisetty S. Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions. BMC Pediatrics, (2018); 18(1): 348.

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, (2004); 114(1): 297-316.

Reimund JM, Duclos B, Arondel Y, Baumann R. Persistent inflammation and immune activation contribute to cholestasis in patients receiving home parenteral nutrition. Nutrition, (2001); 17(4): 300-304.

Pierro A, Carnielli V, Filler RM, Smith J, Heim T. Metabolism of intravenous fat emulsion in the surgical newborn. Journal of Pediatric Surgery, (1989); 24(1): 95-101.

Donnell SC, Lloyd DA, Eaton S, Pierro A. The metabolic response to intravenous medium-chain triglycerides in infants after surgery. The Journal of Pediatrics, (2002); 141(5): 689-694.

Zou TT, Li JR, Zhu Y, Wan CM, Liao Q. Fish oil-containing lipid emulsions prevention on parenteral nutrition-associated cholestasis in very low birth weight infants: a meta-analysis. World Journal of Pediatrics, (2022); 18(7): 463-471.

Kalfarentzos F, Kokkinis K, Leukaditi K, Maroulis J, Onoufriou A, et al. Comparison between two fat emulsions: Intralipid 30 cent vs intralipid 10 cent in critically ill patients. Clinical Nutrition, (1998); 17(1): 31-34.

Yu LJ, Anez-Bustillos L, Mitchell PD, Ko VH, Secor JD, et al. Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion. JPEN Journal of parenteral and enteral nutrition, (2023); 47(1): 30-40.

Chen IL, Hung CH, Huang HC. Smoflipid Is Better Than Lipofundin for Long-Term Neurodevelopmental Outcomes in Preterm Infants. Nutrients, (2021); 13(8) 2548.

Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition, (2009); 48(2): 209-215.

Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN Journal of parenteral and enteral nutrition, (2012); 36(1): 81-94.

Pawlik D, Lauterbach R, Walczak M, Hurkała J, Sherman MP. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN Journal of parenteral and enteral nutrition, (2014); 38(6): 711-716.

Hojsak I, Colomb V, Braegger C, Bronsky J, Campoy C, et al. ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis. Journal of Pediatric Gastroenterology and Nutrition, (2016); 62(5): 776-792.

Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews, (2008); (1): Cd000503.

Jiang W, Chen G, Zhang J, Lv X, Lu C, et al. The effects of two mixed intravenous lipid emulsions on clinical outcomes in infants after gastrointestinal surgery: a prospective, randomized study. Pediatric Surgery International, (2019); 35(3): 347-355.

Hanindita MH, Irawan R, Ugrasena IDG, Hariastawa AIGB Comparison of two lipid emulsions on interleukin-1β, interleukin-8 and fatty acid composition in infants post gastrointestinal surgery: a randomized trial. F1000Research, (2020); 9: 1168.

Johnson PJ. Review of macronutrients in parenteral nutrition for neonatal intensive care population. Neonatal Network, (2014); 33(1): 29-34.

Mihatsch WA, Braegger C, Bronsky J, Cai W, Campoy C, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition. Clinical Nutrition, (2018); 37(6): 2303-2305.

Skouroliakou M, Konstantinou D, Agakidis C, Delikou N, Koutri K, et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Nutrition in Clinical Practice, (2012); 27(6): 817-824.

Calkins KL, Havranek T, Kelley-Quon LI, Cerny L, Flores M, et al. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders. Journal of Parenteral and Enteral Nutrition, (2017); 41(3): 404-411.




DOI: http://dx.doi.org/10.62940/als.v11i4.3442

Refbacks

  • There are currently no refbacks.